featured
Dermatology Evaluation for Cutaneous Immune-Related AEs Is Associated With Improved Survival in Patients With Cancer Treated With Checkpoint Inhibition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dermatology evaluation for cutaneous immune related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition
J Am Acad Dermatol 2022 Sep 13;[EPub Ahead of Print], TV Jacoby, N Shah, MS Asdourian, LL Thompson, TS Otto, NR LeBoeuf, Y Semenov, E Christopher Dee, KL Reynolds, ST ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.